Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background Chemotactic cytokines, referred to as chemokines, play an important role in leukocyte trafficking. The circulating levels of chemokines have been shown to increase in inflammatory processes including obesity-related pathologies (e.g. atherosclerosis and diabetes). However, little is currently known about the relationship between chemokines and human obesity. In the present study, we investigated the circulating levels of selected chemokines (monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1alpha (MIP-1alpha), leukotactin-1, interleukin-8 (IL-8)) and the association between the chemokine levels and obesity-related parameters: body mass index (BMI), waist circumference, fasting glucose and insulin levels, lipids profile, and the level of C-reactive protein (CRP).Methods A total of 100 subjects, 50 obese (BMI>or=25 kg/m2) and 50 who were not obese (BMI<25 kg/m2) participated in the present study. The levels of chemokines and CRP were measured in a fasting state serum by sandwich enzyme-linked immunosorbent assay. Total cholesterol, high-density lipoprotein (HDL)-cholesterol, triglyceride, glucose, and insulin levels were measured by enzymatic analysis and immunoassay.Results The circulating levels of MCP-1 and IL-8 in the serum were significantly (P<0.05) higher in obese subjects (BMI>30 kg/m2) compared with those of nonobese controls (BMI<25 kg/m2). The levels of CRP were positively correlated with BMI (P<0.001) or waist circumference (P<0.0001). The levels of MCP-1 and IL-8 were positively related to BMI (MCP-1, P<0.02; IL-8, P<0.01) and/or waist circumference (MCP-1, P<0.009; IL-8, P<0.03). The levels of MCP-1 were positively related to the levels of CRP (P<0.007) or interleukin-6 (IL-6) (P<0.0001), and negatively related to the levels of HDL-cholesterol (P<0.01). Homeostasis model assessment (HOMA) score was positively related to the levels of MCP-1 (P<0.02) or IL-8 (P<0.03) in obese subject.Discussion Our data demonstrated that the circulating levels of MCP-1 and IL-8 are related to obesity-related parameters such as BMI, waist circumference, CRP, IL-6, HOMA and HDL-cholesterol. These findings suggest that the circulating MCP-1 and/or IL-8 may be a potential candidate linking obesity with obesity-related metabolic complications such as atherosclerosis and diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Components of the SASP, such as interleukin (IL)-6, IL-8, and MCP-1, are increased in obese adults and adolescents and could contribute to such a proinflammatory state, together with effects of macrophages and other mediators of inflammation (31,53,54).”
From Cellular Senescence in Type 2 Diabetes: A Therapeutic Opportunity (2015) · cites this paper as [53]
In the citing paper
“Patients with type 2 diabetes exhibit a higher postprandial inflammatory response than non-diabetics, irrespective of their body weight (165,166) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [165]
In the citing paper
“The magnitude of the postprandial inflammatory response appears to correlate with the degree of insulin resistance (165) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [165]
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Elevated C-reactive protein levels in overweight and obese adults
Visser, M. (1999) · JAMA · doi:10.1001/jama.282.22.2131 · Cited by 2,494
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
Gerszten, R. E., Garcia-Zepeda, E. A., Lim, Y.-C., Yoshida, M., Ding, H. A., Gimbrone, M. A., Luster, A. D., Luscinskas, F. W., & Rosenzweig, A. (1999) · Nature · doi:10.1038/19546 · Cited by 1,244
Monocyte chemoattractant protein 1 in obesity and insulin resistance
Sartipy, P., & Loskutoff, D. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133870100 · Cited by 1,201
Is obesity an inflammatory condition?
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00672-4 · Cited by 799 · cited 1×
“Several lines of evidence suggest that obesity is a low-grade systemic inflammatory condition accompanied by increased levels of circulating C-reactive protein (CRP) andsor other inflammatory cytokines such as tumor necrosis factor alpha (TNF α ) and interleukin-6 (IL-6)”
Background
Cited by
Items 201–300 of 529
Nguyen, N.-D., Kim, J. H., & Kim, M. K. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0255 · Cited by 35
Self-citationObesity Impact on SARS-CoV-2 Infection: Pros and Cons “Obesity Paradox”—A Systematic Review
Vulturar, D.-M., Crivii, C. B., Orasan, O. H., Palade, E., Buzoianu, A. D., Zehan, I.-G., & Todea, D. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11133844 · Cited by 38
“The levels of these cytokines in healthy and obese patients are elevated [85,86].”
BackgroundObesity Related Alterations in Plasma Cytokines and Metabolic Hormones in Chimpanzees
Nehete, P. N., Magden, E. R., Nehete, B. N., Hanley, P. W., & Abee, C. R. (2014) · International Journal of Inflammation · doi:10.1155/2014/856749 · Cited by 35
“This finding could be related to the fact that obesity is known to be associated with a chronic state of low-grade inflammation [39].”
Trail (TNF-related apoptosis-inducing ligand) induces an inflammatory response in human adipocytes
Zoller, V., Funcke, J., Roos, J., Dahlhaus, M., Hay, M. Y. A. E., Holzmann, K., Marienfeld, R. B., Kietzmann, T., Debatin, K., Wabitsch, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05932-7 · Cited by 38
Spigoni, V., Fantuzzi, F., Fontana, A., Cito, M., Derlindati, E., Zavaroni, I., Cnop, M., Bonadonna, R. C., & Dei, A. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.09.004 · Cited by 35
Guo, Y., Qian, H., Xin, X., & Liu, Q. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1405094 · Cited by 41
Dietary factors and low-grade inflammation in relation to overweight and obesity revisted
Calder, P. C. (2022) · British Journal Of Nutrition · doi:10.1017/s0007114522000782 · Cited by 35
Sánchez-Medina, A., Redondo-Puente, M., Dupák, R., Bravo, L., Goya, L., & Sarriá, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021440 · Cited by 32
“Obesity is characterized by a chronic state of low-grade inflammation in which circulating levels of several inflammatory markers, such as IL-6 and MCP-1 [33], and IL-8 [6] are significantly higher compared to the nonobese.”
BackgroundBannitz, R. F., Welendorf, C. R., Coelho, P. O., Salgado, W., Nonino, C. B., Beraldo, R. A., & Foss‐Freitas, M. C. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00623-w · Cited by 32
Listyoko, A. S., Okazaki, R., Harada, T., Inui, G., & Yamasaki, A. (2024) · Frontiers in Allergy · doi:10.3389/falgy.2024.1365801 · Cited by 33
Al‐Rashed, F., Sindhu, S. T. A. K., Madhoun, A. S. A., Ahmad, Z., AlMekhled, D., Azim, R., Al-Kandari, S., Wahid, M. A.-A., Al‐Mulla, F., & Ahmad, R. (2021) · Scientific Reports · doi:10.1038/s41598-021-93449-5 · Cited by 31
Guo, H., Wan, C., Zhu, J., Jiang, X., & Li, S. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1377792 · Cited by 33
Al-Roub, A., Akhter, N., Al-Sayyar, A., Wilson, A., Thomas, R., Kochumon, S., Al‐Rashed, F., Al‐Mulla, F., Sindhu, S. T. A. K., & Ahmad, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147683 · Cited by 30
“In obese mice and humans, MCP-1 and TNFα production are increased in both plasma and adipose tissue [17,29].”
BackgroundThe associations between whole grain and refined grain intakes and serum C-reactive protein
Taskinen, R. E., Hantunen, S., Tuomainen, T., & Virtanen, J. K. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-00996-1 · Cited by 32
Pradeep, A. R., Kumari, M., Kalra, N., & Priyanka, N. (2013) · Cytokine · doi:10.1016/j.cyto.2012.12.022 · Cited by 33
Jemaa, R., Rojbani, H., Kallel, A., Ali, S. B., Feki, M., Chabrak, S., Elasmi, M., Taieb, S. H., Sanhaji, H., Omar, S., et al. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2008.01.004 · Cited by 30
Bimodal impact of skeletal muscle on pancreatic β‐cell function in health and disease
Plomgaard, P., Halban, P. A., & Bouzakri, K. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01641.x · Cited by 28
“Plasma IL-8 is increased with the acute inflammatory response [64], insulin resistance [65] and obesity [66].”
BackgroundJanowska, J., Chudek, J. T., Olszanecka‐Glinianowicz, M., Semik-Grabarczyk, E., & Zahorska‐Markiewicz, B. (2016) · International Journal of Medical Sciences · doi:10.7150/ijms.14110 · Cited by 32
“As prospective studies indicate, an increase in the concentrations of this chemokine is closely associated with an higher risk of the incidence of cardiovascular disease, in particular in the obese patients [56].”
BackgroundZhu, J., Chen, B. Y., & Wilding, J. P. H. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.115 · Cited by 31
Phenotypic variance in pediatric obstructive sleep apnea
Tan, H., & Kaditis, A. G. (2021) · Pediatric Pulmonology · doi:10.1002/ppul.25309 · Cited by 31
“reported to be elevated in obesity unrelated to OSAS and are believed to contribute to atherosclerosis and the metabolic syndrome.(12,13) The inflammatory and genetic influences on end‐organ function”
BackgroundExtracellular Vesicles as Carriers of Adipokines and Their Role in Obesity
Camino, T., Lago‐Baameiro, N., & Pardo, M. (2023) · Biomedicines · doi:10.3390/biomedicines11020422 · Cited by 29
“It is also interesting to note the presence of IL-8 in subcutaneous vesicles from obese patients, as the presence of this cytokine is positively correlated with obesity-associated parameters, such as BMI (Body Mass Index), WC (waist circumference), and the C-reactive protein level, which indicates inflammation status…”
BackgroundLi, D., lv, X. Y., Wang, B. J., Wang, Y. Q., Mu, H., Feng, Z. L., & Liu, P. (2014) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-014-2651-1 · Cited by 28
Neelofar, K., Arif, Z., Arafat, M. Y., Alam, K., & Ahmad, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27763 · Cited by 28
Inflammatory Biomarkers Levels in T2DM Emirati Patients with Diabetic Neuropathy
Mussa, B. M., Srivastava, A., Al-Habshi, A., Mohammed, A. K., Halwani, R., & Abusnana, S. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s319863 · Cited by 26
“This finding was supported by other investigations which showed a strong correlation between chemotactic cytokines, MCP-1 and IL-8 and various physiological conditions including accumulation of adipose tissues, diabetes and atherosclerosis.(36) In addition, a correlation between levels of MCP-1 and TGF-β has been docu…”
ResultNelson, R. K., & Horowitz, J. F. (2014) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2013-0525 · Cited by 27
“Pro-inflammatory cytokines, including: IL-1 , IL-6, TNF- , and MCP-1 are associated with insulin resistance (Olefsky and Glass 2010), and plasma concentrations of these cytokines are often found to be elevated in overweight and obese adults (Bruun et al. 2003; Kim et al. 2006).”
Vieira, R. A. L., de Freitas, R. N., & Volp, A. C. P. (2014) · Nutrición Hospitalaria · doi:10.3305/nh.2014.30.2.7416 · Cited by 28
Nuszkiewicz, J., Kukulska-Pawluczuk, B., Piec, K., Jarek, D. J., Motolko, K., Szewczyk‐Golec, K., & Woźniak, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13144258 · Cited by 27
“[156,194,251,300]”
A Potential Role for Pro-Inflammatory Cytokines in the Development of Insulin Resistance in Horses
Suagee, J. K., Corl, B. A., & Geor, R. J. (2012) · Animals · doi:10.3390/ani2020243 · Cited by 28
“Serum concentrations of MCP-1 are significantly correlated to body mass index, waist circumference, and other inflammatory markers in humans, mRNA is increased in adipose tissue of obese mice, and an intravenous infusion of MCP-1 increases macrophage infiltration into mouse adipose tissue [39–44].”
BackgroundTani, A., Yasui, T., Matsui, S., Kato, T., Kunimi, K., Tsuchiya, N., Yuzurihara, M., Kase, Y., & Irahara, M. (2013) · Cytokine · doi:10.1016/j.cyto.2013.02.011 · Cited by 25
Elumalai, A., & Jain, S. K. (2016) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2664-7 · Cited by 29
“MCP-1 is an important factor involved in inflammatory processes and induces the inflammation of adipocytes and microvasculature [50].”
BackgroundPhillips, B. E., Lantier, L., Engman, C., Garciafigueroa, Y., Singhi, A. D., Trucco, M., Mantzoros, C. S., Wasserman, D. H., & Giannoukakis, N. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01564-y · Cited by 24
“Another CXCR2 ligand, IL-8, was shown to be elevated in the circulation of obese individuals [18] and its steady-state circulating levels correlate well with adiposity and insulin resistance [19].”
BackgroundCura–Esquivel, I., Perales-Quintana, M. M., Torres-González, L., Avilan, K. G., Muñoz-Espinosa, L. E., & Cordero‐Pérez, P. (2023) · PLoS ONE · doi:10.1371/journal.pone.0281381 · Cited by 27
“MCP-1 levels were also correlated with waist and hip circumferences, BMI, and DBP. Kim et al. found similar correlations with BMI and WC in young Koreans [21].”
ResultTretjakovs, P., Jurka, A., Bormane, I., Mackēvičs, V., Miķelsone, I., Balode, L., Reihmane, D., Stuķēna, I., Bahs, G., Aivars, J. I., et al. (2009) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2009.08.004 · Cited by 25
Novel aspects of adipocyte-induced skeletal muscle insulin resistance
Eckardt, K., Sell, H., & Eckel, J. (2008) · Archives of Physiology and Biochemistry · doi:10.1080/13813450802404761 · Cited by 30
“IL-8 and MCP-1 are both pro-inflammatory chemokines being increased in serum of obese and diabetic patients (Kim et al., 2006; Sartipy & Loskutoff, 2003).”
BackgroundMilewska, M., Domoradzki, T., Majewska, A., Błaszczyk, M., Gajewska, M., Hulanicka, M., Ciecierska, A., & Grzelkowska‐Kowalczyk, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28568 · Cited by 24
“It is believed that IL‐8 is associated with obesity and several metabolic effects of IL‐8 were already described in context of metabolic disturbances and insulin resistance (Kim et al., 2006; Kobashi et al., 2009; Samaras et al., 2010).”
BackgroundWang, Q., Perrard, X. D., Perrard, J. L., Mansoori, A., Smith, C. W., Ballantyne, C. M., & Wu, H. (2010) · Obesity · doi:10.1038/oby.2010.213 · Cited by 24
“As circulating MCP-1 levels have been shown to be associated with atherosclerotic disease and obesity-related metabolic dysfunctions (39,40), the reduced plasma MCP-1 levels with rimonabant treatment may also contribute to the favorable effects of rimonabant on the risks for these obesityrelated disorders.”
BackgroundAltamura, S., Lombardi, F., Palumbo, P., Cinque, B., Ferri, C., Pinto, R. D., & Pietropaoli, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413633 · Cited by 25
Activation of IRF1 in Human Adipocytes Leads to Phenotypes Associated with Metabolic Disease
Friesen, M., Camahort, R., Lee, Y., Xia, F., Gerszten, R. E., Rhee, E. P., Deo, R. C., & Cowan, C. A. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.014 · Cited by 24
“We also demonstrate elevated MCP-1, which leads to inflammation and is associated with obesity, insulin resistance, and altered adipocyte metabolism (Kanda et al., 2006; Kim et al., 2006).”
BackgroundAlvehus, M., Šimonytė, K., Andersson, T., Söderström, I., Burén, J., Rask, E., Mattsson, C., & Olsson, T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04322.x · Cited by 26
Adipose tissue and metabolic and inflammatory responses to stroke are altered in obese mice
Haley, M., Mullard, G., Hollywood, K., Cooper, G., Dunn, W., & Lawrence, C. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030411 · Cited by 27
“However, previous reports in patients suggest that plasma CCL2 levels increase with obesity (Kim et al., 2006), potentially explaining the high basal levels found here, although the reason for the reduction in CCL2 after stoke in obese animals is unclear.”
Okamoto, T., Sugimoto, S., Noda, M., Yokooji, T., Danshiitsoodol, N., Higashikawa, F., & Sugiyama, M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01159 · Cited by 23
Klevebro, S., Björkander, S., Ekström, S., Merid, S. K., Gruzieva, O., Mälarstig, A., Johansson, Å., Kull, I., Bergström, A., & Melén, E. (2021) · Scientific Reports · doi:10.1038/s41598-021-90843-x · Cited by 25
Bottero, V., & Potashkin, J. A. (2020) · Nutrients · doi:10.3390/nu12123765 · Cited by 23
“IL8 might play a role in some obesity-related metabolic complications [69].”
BackgroundObesity as a comorbidity in children and adolescents with autoimmune rheumatic diseases
Held, M., Šestan, M., & Jelušić, M. (2022) · Rheumatology International · doi:10.1007/s00296-022-05238-6 · Cited by 23
“Previous researches has shown an interrelation between IL-8 and obesity both in adult [14, 15] and female adolescent population [16], but not in younger children and male adolescents.”
BackgroundYasui, T., Saijo, A., Uemura, H., Matsuzaki, T., Tsuchiya, N., Yuzurihara, M., Kase, Y., & Irahara, M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0063 · Cited by 22
Sekikawa, A. M., Kadowaki, T., Curb, J. D., Evans, R. G., Maegawa, H., Abbott, R. D., Sutton-Tyrrell, K., Okamura, T., Shin, C., Edmundowicz, D., et al. (2010) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0114 · Cited by 23
Bak, E., Choi, K., Jang, S., Woo, G., Yoon, H., Na, Y., Yoo, Y., Lee, Y., Jeong, Y., & Cha, J. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2015.03.005 · Cited by 22
“The elevated expression of MCP-1 has been shown to be associated with obesity related metabolic disorders [5,24].”
BackgroundLima, R. S., de Mattos, R. T., Medeiros, N. I., Kattah, F. M., Nascimento, J. R. S., Menezes, C. A., Rios-Santos, F., Dutra, W. O., Gomes, J. D. A. S., & Moreira, P. R. (2021) · Cytokine · doi:10.1016/j.cyto.2021.155538 · Cited by 22
Liukkonen, M., Paterno, J. J., Kivinen, N., Siintamo, L., Koskela, A. K. J., & Kaarniranta, K. (2021) · Acta Ophthalmologica · doi:10.1111/aos.15051 · Cited by 23
Yasui, T., Uemura, H., Yamada, M., Matsuzaki, T., Tsuchiya, N., Noguchi, M., Yuzurihara, M., Kase, Y., & Irahara, M. (2008) · Cytokine · doi:10.1016/j.cyto.2007.12.001 · Cited by 22
Chemokine and chemokine receptor gene expression in the mesenteric adipose tissue of KKAy mice
Lee, H.-S., Park, J., Kang, J., Kawada, T., Yu, R., & Han, I. (2009) · Cytokine · doi:10.1016/j.cyto.2008.12.025 · Cited by 20
“Recently, a causal relationship between obesity, white adipose tissue inflammation, and insulin resistance was demonstrated for macrophage infiltration enhanced by MCP-1 and its receptor, CCR2: MCP-1, in adipose tissue [6,7], as well as for insulin resistance, and hepatic steatosis in obesity [35].”
BackgroundSelf-citationInflammatory markers in a randomised soya intervention among men
Maskarinec, G., Oum, R. E., Chaptman, A. K., & Ognjanovic, S. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508147389 · Cited by 20
“Since the elevated circulatory levels of MCP-1 in obese subjects are associated with a number of obesity parameters, it appears that serum levels reflect concentrations in adipose tissue((29)).”
BackgroundBenson, T. W., Weintraub, D. S., Crowe, M., Yiew, N. K. H., Popoola, O., Pillai, A., Joseph, J. P., Archer, K., Greenway, C., Chatterjee, T. K., et al. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.01.006 · Cited by 20
“, 2008), correlating with the degree of insulin resistance (Kim et al., 2006).”
BackgroundGoh, K. J., Chen, J., Rocha, N., & Semple, R. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-64136-8 · Cited by 22
Which salivary components can differentiate metabolic obesity?
Ostrowska, L., Gornowicz, A., Pietraszewska, B., Bielawski, K., & Bielawska, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0235358 · Cited by 21
“Serum IL-8 levels were also positively related to BMI and waist circumference [20].”
BackgroundPatel, H. H., Trooskin, S. Z., Shapses, S. A., Sun, W. C., & Wang, X. (2014) · Endocrine Practice · doi:10.4158/ep14104.or · Cited by 19
O’Sullivan, K. E., Reynolds, J. V., O’Hanlon, C., O'Sullivan, J. N., & Lysaght, J. (2013) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-013-9555-x · Cited by 20
“Plasma levels of IL-8 are significantly higher in obese (BMI>30 kg/m(2)) than non-obese (BMI<25 kg/m(2)) subjects [102].”
Bultinck, J., Yuan, S., Cantuti‐Castelvetri, L., Brosens, L., Bracke, D., Collins, J., Goethals, J., Christianson, C. A., Nuss, J. M., & Ogilvie, K. M. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102282 · Cited by 21
“Multiple inflammatory mediators associated with obesity-related complications such as TNF [65], IFN-γ [66], MCP-1 [67], CCL5 [68], resistin [69], and FABP4 [70], were significantly reduced by VTX3232 treatment in DIO mice.”
Nutrigenomics and Proteomics in Health and Disease: Food Factors and Gene Interactions
Mine, Y., Miyashita, K., & Shahidi, F. (2009) · Wiley eBooks · doi:10.1002/9780813807263 · Cited by 22
Vargas-Sánchez, K., Vargas, L., Urrutia, Y., Beltrán, I., Rossi, A. B., Lozano, H. Y., Guarín, J., & Losada-Barragán, M. (2020) · Journal of Inflammation · doi:10.1186/s12950-020-00264-2 · Cited by 18
Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer
Roškar, L., Roškar, I., Rižner, T. L., & Smrkolj, Š. (2021) · Biomolecules · doi:10.3390/biom12010007 · Cited by 21
“IL-8 is also produced and secreted by adipocytes, and its levels increase with BMI and waist circumference, which is also associated with EC incidence and outcomes [93].”
BackgroundSamaan, M. C., Obeid, J., Nguyen, T., Thabane, L., & Timmons, B. W. (2013) · BMC Pediatrics · doi:10.1186/1471-2431-13-47 · Cited by 18
“Circulating CCL2 levels are increased in obese adults and children [21,22], and correlate positively with BMI and other inflammatory markers like C-Reactive Protein and Interleukin-6 and negatively with High Density lipoprotein (HDL) [23].”
BackgroundInfluentialErol, A. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2008.03.028 · Cited by 18
“negatively related to the levels of HDL [38].”
BackgroundCytokine responses to repeated, prolonged walking in lean versus overweight/obese individuals
Verheggen, R. J. H. M., Eijsvogels, T. M. H., Catoire, M., Terink, R., Ramakers, R. E. F. S., Bongers, C. C. W. G., Mensink, M., Hermus, A. R., Thijssen, D. H. J., & Hopman, M. T. E. (2018) · Journal of science and medicine in sport · doi:10.1016/j.jsams.2018.07.019 · Cited by 21
Kim, S.-H., Lee, J., Im, J., & Hwang, H. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.519047 · Cited by 18
“Both MCP-1 and IL-8 were positively related to the HOMA-IR index in obese subjects [33], suggesting that these chemokines contribute to insulin Table II.”
BackgroundLempesis, I. G., Hoebers, N., Essers, Y. P. G., Jocken, J. W. E., Dineen, R., Blaak, E. E., Manolopoulos, K. N., & Goossens, G. H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1205799 · Cited by 18
Schinzari, F., Tesauro, M., Campia, U., & Cardillo, C. (2020) · Vascular Pharmacology · doi:10.1016/j.vph.2020.106676 · Cited by 17
Franco, L., Williams, F. M. K., Trofimov, S., Surdulescu, G. L., Spector, T. D., & Livshits, G. (2013) · Metabolism · doi:10.1016/j.metabol.2013.02.001 · Cited by 17
“Several cytokines such as IL-6, TNF-α, MCP-1 and IL-8 have been found to be increased in the serum of obese subjects [8–10].”
BackgroundSindhu, S. T. A. K., & Wilson, A. (2015) · Journal of Glycomics & Lipidomics · doi:10.4172/2153-0637.1000136 · Cited by 17
“The present data showing the increased IL-18/CRP expression in obesity are in agreement, at least in part, with previous reports [27-33].”
ResultMoreira, R., Oliveira, P. F., Spadella, M. A., Ferreira, R. M., & Alves, M. G. (2025) · Antioxidants · doi:10.3390/antiox14020150 · Cited by 22
“Additionally, the expanding adipose tissue directly produces MCP-1 [58], which not on contributes to the establishment of systemic insulin resistance by undermining insulin signaling at Akt phosphorylation and ERK activation but is also associated with increased adipose inflammation [59].”
Deconstructing metabolic inflammation using cellular systems
Chan, K. L., Boroumand, P., Milanski, M., Pillon, N. J., Bilan, P. J., & Klip, A. (2017) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00039.2017 · Cited by 18
COVID-19 and liver injury in individuals with obesity
Lempesis, I. G., Karlafti, E., Papalexis, P., Fotakopoulos, G., Tarantinos, K., Lekakis, V., Papadakos, S. P., Cholongitas, Ε., & Georgakopoulou, V. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i6.908 · Cited by 16
Yasui, T., Uemura, H., Hyodo, S., Yamada, M., Yamamoto, S., Maegawa, M., Tsuchiya, N., Noguchi, M., Yuzurihara, M., Kase, Y., et al. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.09.014 · Cited by 16
When fat becomes an ally of the enemy: adipose tissue as collaborator in human breast cancer
Lapeire, L., Denys, H. G., Cocquyt, V., & Wever, O. D. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0018 · Cited by 17
Bose, T., López-Alvarenga, J. C., Tejero, M. E., Voruganti, V. S., Proffitt, J. M., FREELAND-GRAVES, J. H., Cole, S. A., & Comuzzie, A. G. (2009) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2009.00379.x · Cited by 16
“In overweight and obese humans who are prone to having low insulin sensitivity, the circulating levels of MCP-1 were positively related to HOMA scores [21].”
BackgroundObesity and type 2 diabetes as chronic inflammation: how does the cytokine evidence align?
Bhatia, K., Gupta, V. K., & Upadhyay, S. K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1721206 · Cited by 18
Role of Epicardial Adipose Tissue Secretome on Cardiovascular Diseases
Leo, S., Tremoli, E., Ferroni, L., & Zavan, B. (2023) · Biomedicines · doi:10.3390/biomedicines11061653 · Cited by 16
Relation of chemokines to BMI and insulin resistance at ages 18–21
Ognjanovic, S., Jacobs, D. R., Steinberger, J., Moran, A. E., & Sinaiko, A. R. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.61 · Cited by 15
Ignacio, R. M. C., Lee, E.-S., Wilson, A. J., Beeghly-Fadiel, A. C., Whalen, M. M., & Son, D. (2018) · Immune Network · doi:10.4110/in.2018.18.e47 · Cited by 15
“Circulating levels of CCL2 were elevated in human obese subjects (53).”
BackgroundCC chemokine ligand 2 (CCL2) stimulates aromatase gene expression in mammary adipose tissue
Martínez‐Chacón, G., Yatkin, E., Polari, L., Dinç, D. D., Peuhu, E., Hartiala, P., Saarinen, N., & Mäkelä, S. (2021) · The FASEB Journal · doi:10.1096/fj.201902485rrr · Cited by 17
Nakamura, S., Yonekura, S., Shimosato, T., & Takaya, T. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.679152 · Cited by 15
“IL-8 is a chemokine that contributes to insulin resistance in patients with T2DM (Kim et al., 2006; Samaras et al., 2010) and is also a myokine released from skeletal muscle cells.”
BackgroundHaam, J.-H., Kim, Y., Koo, H. S., Haam, J., Seo, N., Kim, H. Y., Park, K., Park, K., & Kim, M. J. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2015.12.003 · Cited by 15
“Previous studies have shown that the levels of MCP-1 are elevated in metabolic syndrome [8, 9].”
BackgroundMatia‐García, I., Salgado-Goytia, L., Muñóz-Valle, J. F., García‐Arellano, S., Hernández‐Bello, J., Salgado-Bernabé, A. B., & Parra‐Rojas, I. (2015) · Disease Markers · doi:10.1155/2015/461208 · Cited by 19
“Several studies have shown that obesity is associated with elevated serum levels of a wide range of inflammatory markers including C-reactive protein (CRP), interleukin 6 (IL-6), interleukin 8 (IL-8), and monocyte chemoattractant protein 1 (MCP-1) [3, 4].”
BackgroundNederveen, J. P., Manta, K., Bujak, A. L., Simone, A. C., Fuda, M. R., Nilsson, M. I., Hettinga, B. P., Hughes, M. C., Perry, C. G. R., & Tarnopolsky, M. A. (2021) · Nutrients · doi:10.3390/nu13113726 · Cited by 14
Iliuta, I.-A., Song, X., Pickel, L., Haghighi, A., Retnakaran, R. R., Scholey, J. W., Sung, H., Steinberg, G. R., & Pei, Y. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.962933 · Cited by 14
“In humans, increased circulating MCP-1 correlates with higher levels of other inflammatory markers such as C-reactive protein (CRP) and interleukin-6 (IL-6), but also obesity, waist circumference, and the homeostatic model assessment for insulin resistance (HOMA-IR) score (Kim et al., 2006).”
BackgroundCirculating adipose tissue proteins involved in atrial fibrillation: An explorative scoping review
Meulendijks, E. R., Krul, S. P. J., Baalman, S. W. E., de Vries, T. A. C., Wesselink, R., Ernault, A. C., Kawasaki, M., Al‐Shama, R., Neefs, J., Limpens, J., et al. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.12.004 · Cited by 15
Kostopoulou, E., Kalavrizioti, D., Davoulou, P., Papachristou, E. C., Sinopidis, X., Fouzas, S., Dassios, T. G., Gkentzi, D., Kyriakou, S. I., Karatza, A., et al. (2024) · Diagnostics · doi:10.3390/diagnostics14040450 · Cited by 15
“The plasma concentrations of MCP-1 have also been found to be increased in adults and children with obesity [9–11], and decrease with weight loss [12].”
BackgroundObesity Modulates the Immune Response to Oxidized LDL in Hypertensive Patients
Fonseca, H. A. R., Fonseca, F. A. H., Monteiro, A. M., Bianco, H. T., Boschcov, P., Brandão, S. A. B., Juliano, L., Gidlund, M., & Izar, M. C. D. O. (2013) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-013-9585-9 · Cited by 19
Cai, W., Qiu, C., Zhang, H., Chen, X., Zhang, X., Meng, Q., & Wei, J. (2017) · Journal of Inflammation · doi:10.1186/s12950-017-0171-6 · Cited by 15
“Circulating IL8 was also found to be elevated in patients with T2D and associated with obesity-related parameters [8, 9].”
BackgroundMendez, R. L., Miranda, C. L., Armour, C. R., Sharpton, T. J., Stevens, J. F., & Kwon, J. Y. (2020) · Current Developments in Nutrition · doi:10.1093/cdn/nzaa072 · Cited by 16
“In humans, circulating concentrations of MCP-1 are significantly higher in obese subjects than nonobese controls, showing positive relations to other systemic inflammatory markers, such as C-reactive protein (CRP) and IL-6 (50).”
BackgroundKrzystek‐Korpacka, M., Kędzior, K., Masłowski, L., Mierzchała-Pasierb, M., Bednarz‐Misa, I., Bronowicka-Szydełko, A., Kubiak, J., Gacka, M., Płaczkowska, S., & Gamian, A. (2019) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/103845 · Cited by 15
Developmental Adipokines and Maternal Obesity InteractionsPreprint
Ahmed, R. G. (2015) · SSRN Electronic Journal · Cited by 15
Mohamadi, A., Shiraseb, F., Mirzababaei, A., Hosseininasab, D., Rasaei, N., Clark, C. C. T., & Mirzaei, K. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/8099382 · Cited by 16
Fontenelle, L. C., Sousa, M. D. P., dos Santos, L. R., Cardoso, B. E. P., de Sousa, T. G. V., Soares, T. D. C., Melo, S. R. D. S., Morais, J. B. S., Dias, T. M. D. S., de Oliveira, F. E., et al. (2022) · Biological Trace Element Research · doi:10.1007/s12011-022-03209-3 · Cited by 14
Combinations of bio-active dietary constituents affect human white adipocyte function in-vitro
Warnke, I., Jocken, J. W. E., Schoop, R., Toepfer, C., Góralczyk, R., & Schwager, J. (2016) · Nutrition & Metabolism · doi:10.1186/s12986-016-0143-5 · Cited by 14
“Given that obesity is recognized as a state of chronic ‘low-grade inflammation’ [10, 11], reducing the secretion of pro- and stimulating anti-inflammatory adipokines with combinations of dietary bio-actives could contribute to manage and treat obesityrelated metabolic complications.”
BackgroundMengel, E., Tillmann, V., Remmel, L., Kool, P., Purge, P., Lätt, E., & Jürimäe, J. (2017) · Obesity · doi:10.1002/oby.21756 · Cited by 14
“(29), who showed that serum IL-8 concentration was a predictive marker of excessive body weight in adults, whereas IL-8 did not increase in adults with mild obesity (30).”
BackgroundSachan, A., Singh, A., Shukla, S., Aggarwal, S., Mir, I. A., & Yadav, R. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100147 · Cited by 15
“Out of the other pro-inflammatory markers; MCP-1, resistin and IL-8 decreased at this time in comparison to the baseline and contrarily IL-6 (p value<0.001) and TNF-α increased.”
BackgroundInfluentialDysregulated cytokine and oxidative response in hyper-glycolytic monocytes in obesity
Radushev, V., Karkossa, I., Berg, J., von Bergen�, M., Engelmann, B., Rolle-Kampczyk, U. E., Blüher, M., Wagner, U. G., Schubert, K. A., & Rossol, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1416543 · Cited by 16
Jensen, R. T., Thuesen, A. C. B., Huang, Y., Stinson, S. E., Juel, H. B., Madsbad, S., Bendtsen, F., Hansen, T. F., & Pedersen, J. S. (2025) · Obesity Surgery · doi:10.1007/s11695-024-07629-z · Cited by 16
Obesity in HIV infection: host-pathogen interaction
Savinelli, S., Kelly, N. E. W., Feeney, E. R., O'Shea, D. B., Hogan, A. E., Overton, E. T., LANDAY, A. L., & Mallon, P. W. G. (2022) · AIDS · doi:10.1097/qad.0000000000003281 · Cited by 12
“In human obesity, MCP-1 correlates with waist circumference and VAT mass [50], and higher MCP-1 levels have been associated with subclinical dyskinesis on echocardiography [51].”
Background
Metadata
- Authors
- Kim, C.-S., Park, H.-S., Kawada, T., Kim, J.-H., Lim, D., Hubbard, N. E., Kwon, B.-S., Erickson, K. L., & Yu, R.
- Affiliations
- University of Ulsan (KR)
- Kyoto University (JP)
- University of California, Davis (US)
- Venue
- International Journal of Obesity
- Published
- 2006-03-14
- Volume
- 30
- Issue
- 9
- Pages
- 1347-1355
- ISSN
- 0307-0565 (ISSN-L)
- 1476-5497
- OpenAlex
- W1994851844
- Cited by
- 511
- References
- 34
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 27 · 2023: 27 · 2022: 34 · 2021: 40 · 2020: 37 · 2019: 28 · 2018: 37 · 2017: 20 · 2016: 26 · 2015: 30 · 2014: 29 · 2013: 31 · 2012: 25
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- International Journal of Obesity (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Korea Science and Engineering Foundation
- Ministry of Education, Science and Technology
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- obesity, MCP-1, interleukin-8, chemokines, MIP-1α, C-reactive protein, interleukin-6, insulin resistance, HOMA index, HDL cholesterol, waist circumference, body mass index, serum cytokines, adipose tissue inflammation
- MeSH terms
- Adult, C-Reactive Protein, Female, Humans, Cholesterol, HDL, Male, Obesity, Biomarkers, Body Mass Index, Interleukin-8, Chemokine CCL2, Waist-Hip Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.